Absci (ABSI) Non-Current Assets (2020 - 2026)
Absci's (ABSI) quarterly Non-Current Assets came in at $63.6 million in Q1 2026, down 16.8% year-on-year from $76.5 million in Q1 2025, and down 4.65% quarter-over-quarter from $66.7 million in Q4 2025.
Absci (ABSI) Non-Current Assets (2020 - 2026) Analysis & Trends
Absci has disclosed Non-Current Assets across 7 years of filings, most recently posting $63.6 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $63.6 million, down 16.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $272.8 million (down 17.74% YoY), and the FY2025 annual result was $66.7 million, down 16.36% from the prior year.
- Non-Current Assets came in at $63.6 million for Q1 2026 at Absci, down from $66.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $139.5 million in Q1 2022 to a low of $63.6 million in Q1 2026.
- The 5-year median for Non-Current Assets is $93.1 million (2024), against an average of $99.0 million.
- Across the five-year window, Non-Current Assets declined 4.32% in 2022 and decreased 28.65% in 2024, its largest moves.
- Absci's Non-Current Assets stood at $134.1 million in 2022, then slipped by 27.9% to $96.7 million in 2023, then declined by 17.52% to $79.8 million in 2024, then dropped by 16.36% to $66.7 million in 2025, then retreated by 4.65% to $63.6 million in 2026.
- The last three Non-Current Assets figures came in at $63.6 million (Q1 2026), $66.7 million (Q4 2025), and $70.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 63.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.62 Mn |
| Dec 31, 2025 | 66.72 Mn |
| Sep 30, 2025 | 70.00 Mn |
| Jun 30, 2025 | 72.49 Mn |
| Mar 31, 2025 | 76.47 Mn |
| Dec 31, 2024 | 79.78 Mn |
| Sep 30, 2024 | 85.09 Mn |
| Jun 30, 2024 | 90.34 Mn |
| Mar 31, 2024 | 93.10 Mn |
| Dec 31, 2023 | 96.72 Mn |
| Sep 30, 2023 | 101.63 Mn |
| Jun 30, 2023 | 106.12 Mn |
| Mar 31, 2023 | 130.49 Mn |
| Dec 31, 2022 | 134.15 Mn |
| Sep 30, 2022 | 138.01 Mn |
| Jun 30, 2022 | 138.43 Mn |
| Mar 31, 2022 | 139.50 Mn |
| Dec 31, 2021 | 153.12 Mn |
| Sep 30, 2021 | 148.45 Mn |
| Jun 30, 2021 | 144.68 Mn |